Stocks / AORT vs HROW

Artivion, Inc. (AORT) vs Harrow, Inc. (HROW)

Artivion, Inc. and Harrow, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.

HROW is the larger company ($1.4B vs $1.0B). On the fundamentals, HROW grows revenue faster (41.0% vs 11.8%); AORT earns a higher net margin (2.2% vs -1.9%); AORT has the stronger return on equity (2.2% vs -9.8%). Over the last five years, HROW returned 298.3% vs -27.5%. On the filings, AORT carries fewer potential red flags (1 vs 3). Full numbers below — the stronger figure on each row is in green.

AI verdict — AORT vs HROW, read from the filings

The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.

 Artivion, Inc. (AORT)Harrow, Inc. (HROW)
Market cap$1.0B$1.4B
Revenue (latest FY)$441.33M$272.30M
Net income (latest FY)$9.77M$-5.14M
Revenue growth (5y CAGR)11.8%41.0%
Net margin2.2%-1.9%
Return on equity2.2%-9.8%
P/E ratio82.3
Dividend yield
Profitable years (of last 10)42
Positive free cash flowYesYes

Performance — AORT vs HROW

Total returns from monthly split- and dividend-adjusted closes; 52-week range from the latest quote. Past performance is not a prediction.

 Artivion, Inc. (AORT)Harrow, Inc. (HROW)
1-year return-33.8%21.2%
3-year return19.7%94.3%
5-year return-27.5%298.3%
10-year return74.3%884.0%
52-week range$19.16–$48.25$28.54–$54.85

Verify the comparison

Use the filing period and source shown by each tool before treating two figures as comparable.

Compare with another company:

See the full AORT vs HROW breakdown

Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.

Open AORT's full financials →   Open HROW's full financials →

More comparisons

Frequently asked questions

Which is bigger, AORT or HROW?

Harrow, Inc. is larger by market capitalization — $1.4B versus $1.0B.

Which grows faster, AORT or HROW?

Over the last five fiscal years, Harrow, Inc. grew revenue faster — 41.0%/yr versus 11.8%/yr, computed from SEC-filed statements.

Where does this data come from?

All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.

Keep exploring

AORT fundamentals → · HROW fundamentals → · All 1,500+ companies → · Free screener →